ZYXI:NSD-Zynex Inc (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 8.27

Change

+0.23 (+2.86)%

Market Cap

N/A

Volume

0.04M

Analyst Target

USD 27.35
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+3.77 (+4.95%)

USD 8.61B
PDCO Patterson Companies Inc

-0.03 (-0.10%)

USD 2.72B
AHG Akso Health Group ADR

+0.09 (+7.56%)

USD 0.35B
EDAP EDAP TMS SA

-0.01 (-0.44%)

USD 0.08B
YI 111 Inc

+0.02 (+0.36%)

USD 0.05B
COSM Cosmos Health Inc.

+0.03 (+3.71%)

N/A
SNYR Synergy CHC Corp. Common Stock

+0.35 (+9.15%)

N/A

ETFs Containing ZYXI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.25% 75% C 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.25% 75% C 64% D
Trailing 12 Months  
Capital Gain -30.15% 50% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.15% 50% F 25% F
Trailing 5 Years  
Capital Gain -5.34% 57% F 47% F
Dividend Return 1.14% 50% F 3% F
Total Return -4.19% 57% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain -3.79% 14% F 29% F
Dividend Return -3.79% 14% F 27% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.22% 71% C- 47% F
Risk Adjusted Return -9.42% 14% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.